Tinka Resources Ltd
XTSX:TK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tinka Resources Ltd
XTSX:TK
|
CA |
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
US |
|
Investigator Resources Ltd
ASX:IVR
|
AU |
|
C
|
CAZ (Thailand) PCL
SET:CAZ
|
TH |
|
Paragon Care Ltd
ASX:PGC
|
AU |
|
Jacquet Metals SA
PAR:JCQ
|
FR |
|
S
|
Sinar Eka Selaras PT
IDX:ERAL
|
ID |
Balance Sheet
Balance Sheet Decomposition
Tinka Resources Ltd
Tinka Resources Ltd
Balance Sheet
Tinka Resources Ltd
| Sep-2002 | Sep-2003 | Sep-2004 | Sep-2005 | Sep-2006 | Sep-2007 | Sep-2008 | Sep-2009 | Sep-2010 | Sep-2011 | Sep-2012 | Sep-2013 | Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2024 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
1
|
1
|
2
|
0
|
0
|
1
|
4
|
2
|
2
|
6
|
7
|
2
|
6
|
14
|
7
|
4
|
4
|
10
|
2
|
6
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
2
|
2
|
6
|
7
|
2
|
6
|
14
|
7
|
4
|
0
|
0
|
0
|
6
|
|
| Cash Equivalents |
0
|
0
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
10
|
2
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
8
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
1
|
1
|
1
|
2
|
0
|
0
|
1
|
5
|
2
|
2
|
6
|
7
|
2
|
6
|
14
|
7
|
21
|
12
|
18
|
2
|
7
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
0
|
1
|
2
|
2
|
2
|
3
|
6
|
10
|
14
|
19
|
22
|
29
|
39
|
46
|
48
|
55
|
60
|
73
|
75
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
0
|
1
|
2
|
2
|
2
|
3
|
6
|
10
|
0
|
0
|
0
|
0
|
39
|
46
|
48
|
55
|
60
|
73
|
75
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
1
+240%
|
2
+38%
|
2
-10%
|
3
+75%
|
3
+0%
|
2
-27%
|
3
+45%
|
8
+146%
|
8
+1%
|
12
+52%
|
20
+66%
|
26
+31%
|
24
-8%
|
35
+47%
|
54
+53%
|
53
-2%
|
69
+31%
|
67
-3%
|
78
+16%
|
75
-4%
|
82
+9%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-67%
|
0
N/A
|
0
+250%
|
0
N/A
|
0
+43%
|
0
+10%
|
0
-36%
|
0
+29%
|
0
-33%
|
0
+100%
|
0
+117%
|
0
+62%
|
1
+31%
|
0
-74%
|
1
+261%
|
1
+15%
|
1
+77%
|
1
-25%
|
1
-24%
|
1
+9%
|
0
-33%
|
1
+86%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
1
|
2
|
4
|
5
|
6
|
8
|
8
|
8
|
10
|
15
|
17
|
22
|
33
|
40
|
40
|
53
|
75
|
75
|
93
|
93
|
105
|
105
|
106
|
|
| Retained Earnings |
2
|
2
|
2
|
3
|
5
|
5
|
6
|
7
|
8
|
8
|
9
|
10
|
14
|
15
|
16
|
19
|
21
|
23
|
25
|
27
|
27
|
30
|
25
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
1
+253%
|
2
+35%
|
2
-10%
|
3
+77%
|
3
N/A
|
2
-27%
|
3
+46%
|
8
+151%
|
8
N/A
|
12
+51%
|
19
+66%
|
25
+31%
|
24
-6%
|
35
+46%
|
53
+54%
|
52
-2%
|
69
+32%
|
67
-3%
|
77
+16%
|
75
-3%
|
81
+9%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
1
+238%
|
2
+39%
|
2
-10%
|
3
+75%
|
3
+0%
|
2
-27%
|
3
+45%
|
8
+146%
|
8
+1%
|
12
+52%
|
20
+66%
|
26
+31%
|
24
-8%
|
35
+47%
|
54
+53%
|
53
-2%
|
69
+31%
|
67
-3%
|
78
+16%
|
75
-4%
|
82
+9%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
1
|
2
|
3
|
4
|
5
|
5
|
5
|
8
|
13
|
14
|
16
|
23
|
30
|
30
|
42
|
53
|
53
|
68
|
68
|
78
|
78
|
82
|
|